Trial Profile
A study to evaluate NAL1239 Fentanyl orally dissolving film (ODF) formulation for treatment of severe cancer pain.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 07 Dec 2016
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Adverse reactions
- 07 Dec 2016 New trial record